Sabra Health Care REIT Statistics
Total Valuation
SBRA has a market cap or net worth of $4.93 billion. The enterprise value is $7.48 billion.
Important Dates
The next estimated earnings date is Monday, August 3, 2026, after market close.
| Earnings Date | Aug 3, 2026 |
| Ex-Dividend Date | May 15, 2026 |
Share Statistics
SBRA has 252.19 million shares outstanding. The number of shares has increased by 4.47% in one year.
| Current Share Class | 252.19M |
| Shares Outstanding | 252.19M |
| Shares Change (YoY) | +4.47% |
| Shares Change (QoQ) | +1.26% |
| Owned by Insiders (%) | 1.65% |
| Owned by Institutions (%) | 104.56% |
| Float | 247.95M |
Valuation Ratios
The trailing PE ratio is 31.00 and the forward PE ratio is 28.42. SBRA's PEG ratio is 3.18.
| Price/FFO Ratio | 13.09 |
| Price/AFFO Ratio | n/a |
| PE Ratio | 31.00 |
| Forward PE | 28.42 |
| PS Ratio | 6.04 |
| Forward PS | 5.51 |
| PB Ratio | 1.77 |
| P/TBV Ratio | 1.81 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 13.44 |
| PEG Ratio | 3.18 |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 47.87 |
| EV / Sales | 9.17 |
| EV / EBITDA | 16.28 |
| EV / EBIT | 27.95 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.62, with a Debt / Equity ratio of 0.96.
| Current Ratio | 2.62 |
| Quick Ratio | 1.99 |
| Debt / Equity | 0.96 |
| Debt / EBITDA | 5.81 |
| Debt / FCF | n/a |
| Interest Coverage | 2.77 |
Financial Efficiency
Return on equity (ROE) is 5.68% and return on invested capital (ROIC) is 4.88%.
| Return on Equity (ROE) | 5.68% |
| Return on Assets (ROA) | 3.09% |
| Return on Invested Capital (ROIC) | 4.88% |
| Return on Capital Employed (ROCE) | 4.88% |
| Weighted Average Cost of Capital (WACC) | 6.24% |
| Revenue Per Employee | $14.06M |
| Profits Per Employee | $2.69M |
| Employee Count | 58 |
| Asset Turnover | 0.15 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, SBRA has paid $1.95 million in taxes.
| Income Tax | 1.95M |
| Effective Tax Rate | 1.23% |
Stock Price Statistics
The stock price has increased by +6.95% in the last 52 weeks. The beta is 0.63, so SBRA's price volatility has been lower than the market average.
| Beta (5Y) | 0.63 |
| 52-Week Price Change | +6.95% |
| 50-Day Moving Average | 19.80 |
| 200-Day Moving Average | 19.30 |
| Relative Strength Index (RSI) | 55.45 |
| Average Volume (20 Days) | 3,707,379 |
Short Selling Information
The latest short interest is 29.35 million, so 11.64% of the outstanding shares have been sold short.
| Short Interest | 29.35M |
| Short Previous Month | 31.37M |
| Short % of Shares Out | 11.64% |
| Short % of Float | 11.84% |
| Short Ratio (days to cover) | 12.60 |
Income Statement
In the last 12 months, SBRA had revenue of $815.66 million and earned $156.19 million in profits. Earnings per share was $0.63.
| Revenue | 815.66M |
| Gross Profit | 519.94M |
| Operating Income | 267.46M |
| Pretax Income | 157.97M |
| Net Income | 156.19M |
| EBITDA | 459.21M |
| EBIT | 267.46M |
| Earnings Per Share (EPS) | $0.63 |
Full Income StatementBalance Sheet
The company has $124.18 million in cash and $2.67 billion in debt, giving a net cash position of -$2.55 billion or -$10.10 per share.
| Cash & Cash Equivalents | 124.18M |
| Total Debt | 2.67B |
| Net Cash | -2.55B |
| Net Cash Per Share | -$10.10 |
| Equity (Book Value) | 2.79B |
| Book Value Per Share | 11.05 |
| Working Capital | 183.49M |
Full Balance SheetCash Flow
| Operating Cash Flow | 366.71M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 196.63M |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
Gross margin is 63.74%, with operating and profit margins of 32.79% and 19.15%.
| Gross Margin | 63.74% |
| Operating Margin | 32.79% |
| Pretax Margin | 19.37% |
| Profit Margin | 19.15% |
| EBITDA Margin | 56.30% |
| EBIT Margin | 32.79% |
| FCF Margin | n/a |